Close

Canaccord Genuity on Life Sciences/Biomedical Devices and Services: 2012 Best Ideas: OraSure (OSUR) and Cepheid (CPHD) Dec 15, 2011 09:29AM
Canaccord Genuity Reiterates a 'Buy' on Cepheid (CPHD); Best in Class Continues to Perform Oct 21, 2011 08:58AM
Canaccord Genuity Reiterates a 'Buy' on Cepheid (CPHD); Updating Model and Raising Price Target Jul 25, 2011 08:35AM
Canaccord Genuity Reiterates a 'Buy' on Cepheid (CPHD); Lab Interviews Support GeneXpert Outlook Jul 14, 2011 09:30AM
Canaccord Genuity on Life Sciences: A Clinical Lab Perspective of C. Difficile Testing Jun 24, 2011 08:54AM


Apr 21, 2011 11:00AM Canaccord Reiterates Buy on Cepheid (CPHD), Raises Target to $36
Mar 17, 2011 01:25PM Canaccord Genuity on Life Sciences: Biomedical Devices and Services - Japan Crisis: What Is The Impact on Diagnostic Companies?
Jan 28, 2011 02:34PM Canaccord Genuity Reiterates a 'Buy' on Cepheid (CPHD); Q4 Results Demonstrate Strong Hospital Interest in MDx
Dec 22, 2010 11:09AM Canaccord Genuity Reiterates a 'Buy' on Cepheid (CPHD); Hospital Labs Look to Reduce MDx Send-Outs
Nov 16, 2010 03:30PM Canaccord Genuity Initiates Coverage on Life Sciences – Biomedical Devices and Services Stocks
Nov 16, 2010 09:14AM Canaccord Genuity Starts Cepheid (CPHD) at Buy, Price Target $27
Nov 16, 2010 09:14AM Canaccord Genuity Starts Cepheid (CPHD) at Buy, Price Target $27